In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei
出版年份 2020 全文链接
标题
In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei
作者
关键词
-
出版物
MOLECULES
Volume 25, Issue 8, Pages 1980
出版商
MDPI AG
发表日期
2020-04-29
DOI
10.3390/molecules25081980
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synergistic anti-cancer activity of CDK4/6 inhibitor palbociclib and dual mTOR kinase inhibitor MLN0128 in pRb-expressing ER-negative breast cancer
- (2019) Takuro Yamamoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
- (2019) Ali S. Alzahrani SEMINARS IN CANCER BIOLOGY
- PI3K/mTOR Pathway Inhibition: Opportunities in Oncology and Rare Genetic Diseases
- (2019) Petra Hillmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice
- (2019) Andreas K Lindner et al. LANCET INFECTIOUS DISEASES
- Leishmania parasites are inhibited by the benzoxaborole AN2690 targeting leucyl-tRNA synthetase
- (2018) Reetika Manhas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Targeting the PI3K pathway in cancer: are we making headway?
- (2018) Filip Janku et al. Nature Reviews Clinical Oncology
- Simultaneously targeting DNA damage repair pathway and mTORC1/2 results in small cell lung cancer growth arrest via ER stress-induced apoptosis
- (2018) Bin Fang et al. International Journal of Biological Sciences
- Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
- (2018) Fatemeh Khadir et al. PLoS Neglected Tropical Diseases
- Chagas disease in Europe: A review for the internist in the globalized world
- (2017) Spinello Antinori et al. European Journal of Internal Medicine
- Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
- (2017) Alicia Ponte-Sucre et al. PLoS Neglected Tropical Diseases
- Visceral leishmaniasis: Revisiting current treatments and approaches for future discoveries
- (2016) Joo Hwan No ACTA TROPICA
- The PI3K/AKT Pathway as a Target for Cancer Treatment
- (2016) Ingrid A. Mayer et al. Annual Review of Medicine
- A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites bothIn VitroandIn Vivoby Targeting Type IB Topoisomerase
- (2016) Sourav Saha et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis
- (2016) Forough Khadem et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness
- (2016) Shilpi Khare et al. NATURE
- Integrin- 10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma
- (2016) T. Okada et al. Cancer Discovery
- The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis
- (2016) Stephen Patterson et al. eLife
- Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity
- (2015) Charles E. Mowbray et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vitro and in Vivo Activity of Multitarget Inhibitors against Trypanosoma brucei
- (2015) Gyongseon Yang et al. ACS Infectious Diseases
- Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis
- (2014) Suman Gupta et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Establishment of a Structure–Activity Relationship of 1H-Imidazo[4,5-c]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness
- (2014) João D. Seixas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Initial testing (stage 1) of the investigational mTOR kinase inhibitor MLN0128 by the pediatric preclinical testing program
- (2014) Min H. Kang et al. PEDIATRIC BLOOD & CANCER
- Global distribution maps of the leishmaniases
- (2014) David M Pigott et al. eLife
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- The Epidemiological Relevance of Family Study in Chagas Disease
- (2013) Inés Zulantay et al. PLoS Neglected Tropical Diseases
- In Vivo Imaging of Trypanosome-Brain Interactions and Development of a Rapid Screening Test for Drugs against CNS Stage Trypanosomiasis
- (2013) Elmarie Myburgh et al. PLoS Neglected Tropical Diseases
- Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
- (2012) B. Markman et al. ANNALS OF ONCOLOGY
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the Congo
- (2012) Emilie Alirol et al. CLINICAL INFECTIOUS DISEASES
- Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
- (2012) Peter GE Kennedy LANCET NEUROLOGY
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages
- (2012) Jair L. Siqueira-Neto et al. PLoS Neglected Tropical Diseases
- Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis
- (2012) Tana Bowling et al. International Journal for Parasitology-Drugs and Drug Resistance
- Trypanosome TOR complex 2 functions in cytokinesis
- (2011) Antonio Barquilla et al. CELL CYCLE
- Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo
- (2011) K.-Y. Chang et al. CLINICAL CANCER RESEARCH
- Target repurposing for neglected diseases
- (2011) Michael P Pollastri et al. Future Medicinal Chemistry
- Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Rapamycin (mTOR) Inhibitor for Treatment of Cancer
- (2011) Qingsong Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Susceptibility of Trypanosomatid Pathogens to PI3/mTOR Kinase Inhibitors Affords a New Opportunity for Drug Repurposing
- (2011) Rosario Diaz-Gonzalez et al. PLoS Neglected Tropical Diseases
- Beyond Rapalog Therapy: Preclinical Pharmacology and Antitumor Activity of WYE-125132, an ATP-Competitive and Specific Inhibitor of mTORC1 and mTORC2
- (2010) K. Yu et al. CANCER RESEARCH
- Target of Rapamycin (TOR)-like 1 Kinase Is Involved in the Control of Polyphosphate Levels and Acidocalcisome Maintenance inTrypanosoma brucei
- (2010) Teresa Cristina Leandro de Jesus et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor
- (2010) Robert Mallon et al. MOLECULAR CANCER THERAPEUTICS
- N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
- (2010) Julie A. Frearson et al. NATURE
- Expansion of the target of rapamycin (TOR) kinase family and function in Leishmania shows that TOR3 is required for acidocalcisome biogenesis and animal infectivity
- (2010) L. Madeira da Silva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
- (2009) M. Vermeersch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Kinetoplastids: related protozoan pathogens, different diseases
- (2008) Ken Stuart et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
- (2008) S.-M. Maira et al. MOLECULAR CANCER THERAPEUTICS
- Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
- (2008) Beth Apsel et al. Nature Chemical Biology
- Rapamycin inhibits trypanosome cell growth by preventing TOR complex 2 formation
- (2008) A. Barquilla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
- (2008) Shane R. Wilkinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes
- (2008) Harry P. de Koning TRENDS IN PARASITOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search